Results 191 to 200 of about 69,426 (314)

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine

Clinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 318-321, February 2026.
In recent years, different national and international regulatory authorities, notably the FDA, have made their adverse event repositories publicly available, offering user‐friendly dashboards. This has led to a large increase in low‐quality, poorly reported research using adverse event reporting databases (e.g., FDA’s Adverse Event Reporting System ...
Charles Khouri, Alex Hlavaty, Michele Fusaroli, Nitin Joshi, Francesco Salvo, Andrew Bate, Antoine Pariente, Emanuel Raschi   +7 more
wiley   +1 more source

A Noisy Signal? Geographic Bias in FAERS Reports Linking Paracetamol to Autism Spectrum Disorder. [PDF]

J Clin Med
Tezel Yalçın H, Yalçın N, Allegaert K, Erkekoğlu P.   +3 more
europepmc   +1 more source

Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka [PDF]

, 2008
Sharmini Gunawardena, Shalini Sri Ranganathan, Rohini Fernandopulle   +2 more
openalex   +1 more source

Uncovering the Key Factors Influencing Phytochemical and Phytopharmacological Properties During Medicinal Plant Processing

eFood, Volume 7, Issue 1, February 2026.
From farm to pharma, this review details the engineering of quality in medicinal plants through a science‐driven approach: it first elucidates how genetic and environmental factors inscribe the plant's phytochemical and phytopharmacological profile before harvest, and then dissects the postharvest techniques and technologies—chemical and thermal pre ...
Elyas Aryakia
wiley   +1 more source

Pharmacovigilance and bioethics: the importance of a neglected relationship. [PDF]

Front Drug Saf Regul
Alvaro G, Müller M, Chhibber R, Fuentes R.   +3 more
europepmc   +1 more source

EFFECT OF POLYPHARMACY IN GERIATRICS POPULATION –A PHARMACOVIGILANCE STUDY

, 2018
Arya K Sreekala, S S Kiron, S Athira, Balakrishnan Valliyott   +3 more
openalex   +1 more source

Characterizing Perinatal Treatment Patterns and Outcomes in Myasthenia Gravis

Muscle &Nerve, Volume 73, Issue 2, Page 269-276, February 2026.
ABSTRACT Introduction/Aims Studies on pregnancy in myasthenia gravis (MG) are limited by small sample sizes or examine a limited number of outcomes. The objective of this study was to estimate the prevalence of perinatal and infant outcomes and characterize perinatal treatment patterns in MG.
Melanie H. Jacobson, Rupa Makadia, Ashley E. L. Anderson, Zia Choudhry, Nathan Hall, Jill Hardin, Sicong Huang, Janice M. Massey, Anna Ostropolets, Ran Sun, Rebecca Zaha, Alexis A. Krumme   +11 more
wiley   +1 more source

Constructing an evaluation framework for primary pharmacovigilance systems in developing countries: a case study from China. [PDF]

Front Pharmacol
Lei S, Lin S, Zhu X, Liu W, Liu Q, Yin L, Feng B.   +6 more
europepmc   +1 more source

Editorial - National pharmacovigilance programme

, 2005
C Adithan
openalex   +1 more source

Pharmacovigilance Analysis of Blinatumomab in Children Based on Clinical Practice Combined with FAERS Database [PDF]

Yingqiu Tu, Xin Lai, Nan Zhong
openalex   +1 more source